Research programme: cannabinoid-COX-2 conjugate therapeutics - Enveric Biosciences
Latest Information Update: 19 Apr 2024
At a glance
- Originator Enveric Biosciences
- Class Small molecules
- Mechanism of Action Cannabinoid receptor modulators; Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Joint disorders